IvaBradinE to Treat MicroalbumiNuria in Patients With Type 2 Diabetes and Coronary Heart Disease
NCT03105219
·
clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Shortfall in funding
Conditions
Diabetic Kidney Disease
Interventions
DRUG:
Ivabradine
OTHER:
Sham Comparator
Sponsor
Nanjing First Hospital, Nanjing Medical University